YX
Insider
Yu Xia
DirectorYu Xia (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Summit Therapeutics Inc. (SMMT). Across 1 priced purchase filing, the average 21-session return was -15.9% from execution and -13.7% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of SMMT (533,617 sh × $18.74, as filed), executed Oct 21 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-15.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-13.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.0M
shares × price, as filed
Last traded
Oct 21 2025
Filed Oct 23 2025
Median ADV $66.4M across their filed names
Open performance→Volume by month
Buys $10.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SMMT
Summit Therapeutics Inc.
SMMT · 1 buy · 0 sells
1 filing
Recent filings
SMMTPURCHASE
Summit Therapeutics Inc.
View filing →
$10.0M533,617 sh × $18.74
Exec Oct 21 2025
Filed Oct 23 2025 · 9:06 PM ET